Panel Discussion

Sunday, March 9, 2025

4:20 PM – 4:35 PM ET

Panel Moderator(s)

William T. Abraham, MD

Professor of Medicine
The Ohio State University
Columbus, Ohio, United States

Disclosure(s): Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 31, 2024); AquaPass: Consultant (Ongoing); Cordio Medical: Consultant (Ongoing); CVRx: Consultant (Ongoing); Innoventric: Consultant (Ongoing); JNJ V-Wave: Salary (Ongoing); SCPharmaceuticals: Board of Directors (Ongoing); Vectorious Medtech: Consultant (Ongoing); White Swell: Consultant (Ongoing); Zoll Respicardia: Consultant (Ongoing)
JoAnn Lindenfeld, MD

Director, Heart Failure and Transplantation
Vanderbilt University
Nashville, Tennessee, United States

Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing)
Ileana L. Pina, MD, MPH

Professor of Medicine
Thomas Jefferson University
Cleveland hts, Ohio, United States

Disclosure(s): BOEHRINGER INGELHEIM IT.SpA.: advisory Board (Ongoing)

Panel Discussant(s)

Scott M. Lilly, MD PhD

Professor
The Ohio State University Wexner Medical Center
Columbus, Ohio, United States

Disclosure(s): Cardiac Dimensions: Consultant (Ongoing); DASI Simulations: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing)
Donna Mancini, MD

Professor of Medicine
Icahn School of Medicine at Mount Sinai
New York, New York, United States

Disclosure(s): No financial relationships to disclose
MM

Martin Maron, MD

Director, HCM Center
Lahey Medical Center, Massachusetts, United States

Disclosure(s): Cytokinetics: Consultant (Ongoing); Edgewise: Consulting Fees (e.g., advisory boards) (Ongoing); imbria: Consultant (Ongoing)
Daniele Massera, MD

Associate Director, Hypertrophic Cardiomyopathy Program
NYU Langone Health
New York, New York, United States

Disclosure(s): Chiesi: Consulting Fees (e.g., advisory boards) (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Cytokinetics: Consulting Fees (e.g., advisory boards) (Terminated); Sanofi: Consulting Fees (e.g., advisory boards) (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Tenaya Therapeutics: Consulting Fees (e.g., advisory boards) (Terminated)
John C. Messenger, MD

Professor of Medicine
University of Colorado School of Medicine
Aurora, Colorado, United States

Disclosure(s): Philips: Institutional grant support--University of Colorado SOM (Ongoing)
CR

Charles D. Resor, MD

Interventional Cardiologist
Tufts Medical Center
Boston, Massachusetts, United States

Disclosure information not submitted.
Matthew Sherwood, MD, MHS

System Director of Interventional Cardiology, Director of Structural Heart Program
Inova Schar Heart and Vascular Institute, Virginia, United States

Disclosure information not submitted.
Yan Topilsky, MD

Head of Non Invasive Cardiology
Tel-Aviv Sourasky Medical Center

Disclosure(s): Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Terminated, December 12, 2024), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 12, 2024)

Disclosure(s):

William T. Abraham, MD: Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 31, 2024); AquaPass: Consultant (Ongoing); Cordio Medical: Consultant (Ongoing); CVRx: Consultant (Ongoing); Innoventric: Consultant (Ongoing); JNJ V-Wave: Salary (Ongoing); SCPharmaceuticals: Board of Directors (Ongoing); Vectorious Medtech: Consultant (Ongoing); White Swell: Consultant (Ongoing); Zoll Respicardia: Consultant (Ongoing)

JoAnn Lindenfeld, MD: Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing)

Ileana L. Pina, MD, MPH: BOEHRINGER INGELHEIM IT.SpA.: advisory Board (Ongoing)

Scott M. Lilly, MD PhD: Cardiac Dimensions: Consultant (Ongoing); DASI Simulations: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edwards Lifesciences LLC: Consultant (Ongoing)

Donna Mancini, MD: No financial relationships to disclose

Martin Maron, MD: Cytokinetics: Consultant (Ongoing); Edgewise: Consulting Fees (e.g., advisory boards) (Ongoing); imbria: Consultant (Ongoing)

Daniele Massera, MD: Chiesi: Consulting Fees (e.g., advisory boards) (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Cytokinetics: Consulting Fees (e.g., advisory boards) (Terminated); Sanofi: Consulting Fees (e.g., advisory boards) (Terminated), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Tenaya Therapeutics: Consulting Fees (e.g., advisory boards) (Terminated)

John C. Messenger, MD: Philips: Institutional grant support--University of Colorado SOM (Ongoing)

Yan Topilsky, MD: Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Terminated, December 12, 2024), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 12, 2024)